Caldera Medical appoints new CFO

[Image courtesy of John Pitstick’s LinkedIn]Caldera Medical this week announced it appointed John Pitstick as chief financial officer and executive VP of corporate development.

The company said the appointment will allow it to focus on advancing Caldera’s position in the women’s health sector with M&A activity during rapid expansion.

Pitstick began his career at Ernst & Young managing a global client base and contributing to several IPOs. Most recently, he was CFO of Dyve Biosciences. He has also served as CFO of Seven Lakes Technologies and Conversant.

As CFO of Caldera Medical, Pitstick’s experience in leading mergers and acquisitions will be pivotal, the company said. His experience includes overseeing transactions exceeding $3 billion and has successfully raised over $1 billion in financing. Caldera has ambitious expansion plans, including strategic acuqisionts to enhance the company’s portfolio and market presence,…

Read more
  • 0

Caldera launches new Desara TVez for stress urinary incontinence

[Image from Caldera Medical]Surgical product developer Caldera Medical announced today that it launched the Desara TVez as part of its Desara portfolio.

Los Angeles-based Caldera’s Desara family of products includes offerings for the treatment of stress urinary incontinence, pelvic organ prolapse and polyps.

According to Caldera’s website, Desara TVez is used through the transvaginal approach with tighter trocar curve that closely contours the pubic bone. The product is available in two trocar diameters (2.7mm and 3mm).

Desara TVez includes enclosed dilator tips to facilitate smoother tissue passage and has an “EZ tab” for the simplified removal of the device.

“Staying true to our commitment of being surgeon and patient-focused, Caldera Medical collaborated with dozens of leading surgeons to bring enhanced ease of use and patient safety to life in the form of Desara TVez,” Caldera Medical CEO Bryon Merade said in t…

Read more
  • 0